Independent fund research. Built on SEC filings.

How we research funds

ETF · Corporate Bond · Invesco

Invesco BulletShares 2028 Corporate Bond ETF (BSCS)

Ticker BSCS · Since 2018-08-09 · · Holdings as of May 31, 2026

Expense ratio
0.1%$10/yr per $10k
5-yr return
+1.5%annualized
1-yr return
+4.1%as of Dec 2024
Net assets
$3.5Ball share classes
Holdings
470

Bottom line

Is BSCS a good fund? The bottom line

BSCS is an actively managed corporate bond ETF from Invesco.

Its expense ratio is 0.1% — about $10 a year on every $10,000 invested, cheaper than 78% of corporate bond funds we track.

It returned +4.1% over one year, +1.5% a year over five years (as of Dec 31, 2024, per its prospectus).

With $3.5 billion in net assets and 470 holdings, its largest position is Invesco Private Prime Fund (5.5%) and the top 10 make up 14.3% of the portfolio.

What stands out

  • Low cost: cheaper than 78% of corporate bond peers
  • 5-year return beat 89% of category peers
  • Broadly diversified (470 holdings)

Updated Nov 19, 2026

What BSCS invests in

The Invesco BulletShares 2028 Corporate Bond ETF (the Fund) seeks to track the investment results (before fees and expenses) of the Invesco BulletShares USD Corporate Bond 2028 Index (the Underlying Index).

To be eligible for inclusion in the Underlying Index, bonds must have at least 18 months to final maturity at the time of issuance.

From the fund's prospectus (filed Jul 28, 2026).

BSCS performance

Fund calendar-year total returns, 2019–2024 2019: +15.6%; 2020: +10.3%; 2021: −1.7%; 2022: −11.3%; 2023: +7.4%; 2024: +4.1% +15.6% 2019 +10.3% 2020 −1.7% 2021 −11.3% 2022 +7.4% 2023 +4.1% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
BSCS+4.1%+1.5%—
Corporate Bond median+7.1%−0.0%+3.0%

Source: Fund prospectus, as of Dec 31, 2024

Full BSCS performance history →

What BSCS costs

On a $10,000 investment, BSCS's 0.1% expense ratio costs about $10 a year. The prospectus estimates $129 in total costs over 10 years (assuming 5% annual returns). The median corporate bond fund charges 0.38%.

See the full BSCS fee table →

BSCS top 10 holdings

#Holding% of fund
1Invesco Private Prime Fund5.50%
2Invesco Private Government Fund2.16%
3CVS Health Corp.1.18%
4Cigna Group (The)0.90%
5Amgen Inc.0.89%
6AerCap Ireland Capital DAC / AerCap Global Aviation Trust0.86%
7Salesforce, Inc.0.83%
8RTX Corp.0.71%
9Sprint Capital Corp.0.62%
10Citibank N.A.0.61%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 14.3% of the fund. See all top 25 holdings and asset mix →

Alternatives to BSCS

Closest equivalent at other fund companies
FamilyFundExpense ratioOverlap
iSharesIBDT iShares iBonds Dec 2028 Term Corporate…0.1%53% Compare

More funds like BSCS →

BSCS FAQ

What is the expense ratio of BSCS?
BSCS's expense ratio is 0.1%, which works out to about $10 a year for every $10,000 invested. The prospectus estimates total costs of $129 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is BSCS a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 78% of corporate bond peers; 5-year return beat 89% of category peers; broadly diversified (470 holdings). This is general information, not personalized advice.
What does BSCS hold?
BSCS's largest holdings are Invesco Private Prime Fund (5.5%), Invesco Private Government Fund (2.2%), CVS Health Corp. (1.2%), Cigna Group (The) (0.9%), Amgen Inc. (0.9%). It holds 470 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is BSCS's 5-year return?
BSCS returned +1.5% a year over the five years ending Dec 31, 2024. Past performance does not guarantee future results.
What is a cheaper alternative to BSCS?
IBDT (iShares iBonds Dec 2028 Term Corporate ETF) overlaps about 53% with BSCS and charges 0.1%.
Who manages BSCS?
BSCS is offered by Invesco through Invesco Exchange-Traded Self-Indexed Fund Trust.